In clinical studies, antipsychotic treatment has been found to promote many forms of neuroplasticity and increases in BDNF expression [101], and increased serum BDNF has been regarded as a candidate biomarker for the successful treatment of depression [102]. This evidence concerns the gene BDNF and major depressive disorder.